ATE207750T1 - Verwendung vom 3-alpha-hydroxy-5alpha-androsta-16-ene als arzneimittel - Google Patents

Verwendung vom 3-alpha-hydroxy-5alpha-androsta-16-ene als arzneimittel

Info

Publication number
ATE207750T1
ATE207750T1 AT96402710T AT96402710T ATE207750T1 AT E207750 T1 ATE207750 T1 AT E207750T1 AT 96402710 T AT96402710 T AT 96402710T AT 96402710 T AT96402710 T AT 96402710T AT E207750 T1 ATE207750 T1 AT E207750T1
Authority
AT
Austria
Prior art keywords
alpha
androsta
ene
hydroxy
5alpha
Prior art date
Application number
AT96402710T
Other languages
English (en)
Inventor
Daniel Philibert
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE207750T1 publication Critical patent/ATE207750T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT96402710T 1995-12-13 1996-12-12 Verwendung vom 3-alpha-hydroxy-5alpha-androsta-16-ene als arzneimittel ATE207750T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514750A FR2742337B1 (fr) 1995-12-13 1995-12-13 Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments

Publications (1)

Publication Number Publication Date
ATE207750T1 true ATE207750T1 (de) 2001-11-15

Family

ID=9485442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96402710T ATE207750T1 (de) 1995-12-13 1996-12-12 Verwendung vom 3-alpha-hydroxy-5alpha-androsta-16-ene als arzneimittel

Country Status (9)

Country Link
US (1) US5696107A (de)
EP (1) EP0779075B1 (de)
JP (1) JPH09176183A (de)
AT (1) ATE207750T1 (de)
DE (1) DE69616484T2 (de)
DK (1) DK0779075T3 (de)
ES (1) ES2162992T3 (de)
FR (1) FR2742337B1 (de)
PT (1) PT779075E (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR676202A (fr) * 1928-06-06 1930-02-20 Serrure à pène applicable aux portes fermant à gauche et à droite
JPS62501909A (ja) * 1985-01-25 1987-07-30 モネル　ケミカル　センシス　センタ− ヒト女性における黄体期不全及び無***を治療する為のアンドロステノ−ル及び硫酸デヒドロエピアンドロステロンを含む男性エッセンスの使用
US5155045A (en) * 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
JPH01115892A (ja) * 1987-10-29 1989-05-09 Mitsubishi Electric Corp 液相成長装置
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
FR2717690B1 (fr) * 1994-03-24 1996-04-26 Roussel Uclaf Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine.
AU5426596A (en) * 1995-05-16 1996-11-29 Salk Institute For Biological Studies, The Modulators for new members of the steroid/thyroid superfamily of receptors

Also Published As

Publication number Publication date
ES2162992T3 (es) 2002-01-16
FR2742337B1 (fr) 1998-03-06
DE69616484D1 (de) 2001-12-06
EP0779075A1 (de) 1997-06-18
FR2742337A1 (fr) 1997-06-20
PT779075E (pt) 2002-04-29
JPH09176183A (ja) 1997-07-08
US5696107A (en) 1997-12-09
EP0779075B1 (de) 2001-10-31
DE69616484T2 (de) 2002-04-04
DK0779075T3 (da) 2002-02-18

Similar Documents

Publication Publication Date Title
DE69627042D1 (de) Isocumarinderivate und deren verwendung in medikamenten
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
ATE199250T1 (de) Sulfonamidocarbonylpyridin-2-carbonsäureamide und ihre verwendung als arzneimittel
ATE94869T1 (de) Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika.
ATE175669T1 (de) Sulfonylaminopyrimidine, ihre herstellung und verwendung als heilmittel
DE69600001D1 (de) Kosmetische Zusammensetzung, die eine Silikonverbindung und einen Fettsäureester enthält
AU3462993A (en) Remedy for dermatopathy and metallothionein inducer
DE69429821T2 (de) Farnesyl-derivate und diese enthaltende arzneimittel
NZ242104A (en) Amides of aminoethylsubstituted benzothiazole, -thiazine, -oxazole and -oxazine derivatives; pharmaceutical compositions thereof
DE69333072D1 (de) Topisch anzuwendendes arzneimittel enthaltend hyaluronsäure und nsaids
ATE121295T1 (de) Augentropfenarzneimittel.
ATE174322T1 (de) Verwendung aromatischer carbonsäurederivate zur herstellung von pharmazeutischen präparaten
DE59611111D1 (de) Phospholipid-derivate von phosphonocarbonsäuren, deren herstellung sowie deren verwendung als antivirale arzneimittel
IT1282778B1 (it) Vitamina "e" acetato quale prodotto per applicazione topica
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
ATE207750T1 (de) Verwendung vom 3-alpha-hydroxy-5alpha-androsta-16-ene als arzneimittel
DE69214710D1 (de) Dirithromycin enthaltendes Arzneimittel
ATE156813T1 (de) (s)-alpha-phenyl-2-pyridinethanamin(s)-malat und seine verwendung als arzneimittel
DE69623656T2 (de) Trans apovincaminsäure-esterderivate als arzneimittel
ATE119394T1 (de) Verwendung von myricetin-3-0-beta-d-glucuronid als arzneimittel.
DK0747037T3 (da) Produkter til mundhygiejne
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
ATE157360T1 (de) Thienocyclopentanonoximether, ihre herstellung und diese enthaltende arzneimittel
DE68906437T2 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee